This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Matthew R Hight
Introduction
Matthew R Hight is an accomplished inventor based in Nashville, TN. He has made significant contributions to the field of molecular biology, particularly in the detection of caspase activity and apoptosis. His work is vital for advancing personalized medicine and improving cancer treatment outcomes.
Latest Patents
Matthew R Hight holds a patent for a compound, composition, and method for detecting caspase activity and/or apoptosis. This molecular probe is suitable for quantification of caspase activity in vivo using positron emission tomography (PET). The embodiments of this invention can detect apoptosis in tumors and serve as a novel, potentially translatable biomarker for predicting response to personalized medicine. He has 1 patent to his name.
Career Highlights
Matthew is affiliated with Vanderbilt University, where he contributes to research and innovation in the field of molecular probes and cancer detection. His work has implications for improving diagnostic techniques and treatment strategies in oncology.
Collaborations
Matthew R Hight collaborates with H Charles Manning, who is also involved in research related to molecular imaging and cancer detection.
Conclusion
Matthew R Hight's innovative work in detecting caspase activity and apoptosis represents a significant advancement in the field of personalized medicine. His contributions are paving the way for improved cancer diagnostics and treatment options.